Randomized Trial of Stepped Palliative Care versus Early Integrated Palliative Care in Patients with Advanced Lung Cancer
Study of Stepped Palliative Care versus Early Integrated Palliative Care in Patients with Advanced Lung Cancer
Sponsor: Massachusetts General Hospital
Enrolling: Male and Female Patients
IRB Number: AAAR8207
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information: Research has shown that early involvement of a team of clinicians that specialize in lessening (or palliating) many of these distressing physical and emotional symptoms and in helping patients and their family cope with a serious illness improves patients and their loved ones experience with their cancer. This team is called palliative care, and consists of physicians and advanced practice nurses (or nurse practitioners) who work closely and collaboratively with your oncology team to care for you and your loved ones. Research shows that when the palliative care team works closely with the oncology team to care for patients with advanced cancer, they may have better symptom control, quality of life, and mood and their loved ones feel less distressed. While we know having palliative care clinicians care for you along with your oncology team may be helpful for you and your loved ones, we do not know the optimal frequency and timing of the visits with palliative care. Specifically, we are unsure if it best for you to see palliative care regularly throughout your illness or only if you are having an issue with your health. This study will compare two different strategies for scheduling your visits with the palliative care clinician. The first strategy is to schedule you to meet with the palliative care clinician regularly each month. We call this strategy early integrated palliative care.
This study is closed
Craig Blinderman, MD, MA
Do You Qualify?
Are you 18 years of age or older? Yes No
Jave you been diagnosed with advanced non-small cell lung cacer (NSCLC), mall cell lung cancer (SCLC), or mesothelioma? Yes No
Were you informed that our disease was advanced within the last eight weeks? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Research Nurse Navigator